V. V. Moroz

Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial

Bernadette Brennan, Laura Kirton, Perrine Marec‐Bérard et al. · The Lancet · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +8

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial

Colin A. Hutchison, Paul Cockwell, V. V. Moroz et al. · The Lancet Haematology · 2019 · 115 citations · Full text

Medicine, Nephrology, Oncology +17

International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol

Jennifer Anderton, V. V. Moroz, Perrine Marec‐Bérard et al. · Trials · 2020 · 113 citations · Full text

Medicine, Oncology, Surgical Oncology +8

The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

V. V. Moroz, David Machin, Barbara Hero et al. · Pediatric Blood & Cancer · 2020 · 65 citations

Medicine, Oncology, Pediatrics +13

A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma

J. Gains, V. V. Moroz, Matthew Aldridge et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 51 citations

Medicine, Oncology, Radiation Oncology +11